Motus GI Reports Fourth Quarter 2020 Financial Results and Provides Corporate Update
March 16, 2021 16:05 ET
|
Motus GI Holdings, Inc.
Signed new 12-month committed volume contracts with two prominent U.S. medical centersReported progress on reimbursement for Pure-Vu System in both inpatient and outpatient markets, starting with CMS...
Motus GI Announces First Patient Enrolled in a Pilot Study Using the Pure-Vu® System for Patients with Lower GI Bleeding Being Conducted by a Leading U.S. Medical Center
March 15, 2021 16:05 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., March 15, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...
Motus GI to Present Pure-Vu GEN2 System at the Centers for Medicare and Medicaid Services ICD-10 Reimbursement Code Committee Meeting
March 08, 2021 08:00 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., March 08, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...
Motus GI to Release Fourth Quarter and Full Year 2020 Results and Provide a Business Update on March 16
March 02, 2021 16:01 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., March 02, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...
Motus GI to Participate in Two Upcoming Investor Conferences in March 2021
March 01, 2021 16:01 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., March 01, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that...
Motus GI Announces U.S. Patent for the Pure-Vu® System’s Connectivity with Nearly All Commercial Colonoscopes to Provide Improved Visualization During Colonoscopy
February 24, 2021 08:00 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...
Motus GI Announces Warrant Exercise Agreement Resulting in Expected Gross Proceeds to the Company of up to $11 Million
January 27, 2021 08:45 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that...
Motus GI Announces European Clearance of Enhanced Pure-Vu® GEN2 System to Harmonize with U.S. Configuration
January 15, 2021 08:00 ET
|
Motus GI Holdings, Inc.
Regulatory approval for enhanced system is a key milestone that supports evaluation of strategic partnership opportunities in the EU- - -U.S. commercial rollout of Pure-Vu® GEN2 System enhancements...
Motus GI Expands Intellectual Property Portfolio with U.S. Patent for the Pure-Vu® System’s Universal Method to Mount on the End of Most Commercial Colonoscopes
January 11, 2021 07:45 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...
Motus GI Announces Clinical Compendium of Pure-Vu System Patient Case Studies As Reported by Several Leading U.S. Hospitals
December 16, 2020 08:00 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...